AMN Healthcare Services (AMN)
(Delayed Data from NYSE)
$61.70 USD
+1.91 (3.19%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $61.00 -0.70 (-1.13%) 7:58 PM ET
5-Strong Sell of 5 5
A Value C Growth D Momentum B VGM
AMN Healthcare Services (AMN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$77.88 | $125.00 | $65.00 | 30.26% |
Price Target
Based on short-term price targets offered by eight analysts, the average price target for AMN Healthcare Services comes to $77.88. The forecasts range from a low of $65.00 to a high of $125.00. The average price target represents an increase of 30.26% from the last closing price of $59.79.
Analyst Price Targets (8 )
Broker Rating
AMN Healthcare Services currently has an average brokerage recommendation (ABR) of 2.11 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 2.11 a month ago based on nine recommendations.
Of the nine recommendations deriving the current ABR, four are Strong Buy, representing 44.44% of all recommendations. A month ago, Strong Buy represented 44.44%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 5 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.11 | 2.11 | 2.11 | 2.11 | 2.11 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/13/2024 | BMO Capital Markets | Jeffrey M Silber | Strong Buy | Strong Buy |
5/10/2024 | Not Identified | Not Identified | Hold | Hold |
5/10/2024 | JMP Securities | Constantine Kyriakos Davides | Strong Buy | Strong Buy |
5/10/2024 | William Blair | Trevor Romeo | Strong Buy | Strong Buy |
5/2/2024 | The Benchmark Company | William Sutherland | Hold | Hold |
4/22/2024 | Truist Securities | Tobey O'Brien Sommer | Strong Buy | Strong Buy |
2/15/2024 | Robert W. Baird & Co. | Mark S Marcon | Not Available | Hold |
11/30/2023 | UBS | Aj Rice | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.11 |
ABR (Last week) | 2.11 |
# of Recs in ABR | 9 |
Average Target Price | $77.88 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 85 of 252 |
Current Quarter EPS Est: | 0.75 |